ProjectHeparegenix – Synthese und Charakterisierung niedermolekularer Inhibitoren der Proteinkinase MKK4
Basic data
Acronym:
Heparegenix
Title:
Synthese und Charakterisierung niedermolekularer Inhibitoren der Proteinkinase MKK4
Duration:
01/01/2020 to 31/12/2021
Abstract / short description:
siehe Vorläuferprojekt, hier handelt es sich nur um eine Verlängerung
Involved staff
Managers
Faculty of Science
University of Tübingen
University of Tübingen
Pharmaceutical Institute
Department of Pharmacy and Biochemistry, Faculty of Science
Department of Pharmacy and Biochemistry, Faculty of Science
Baden-Württemberg Center for Brazil and Latin America
Branch offices and other central facilities
Branch offices and other central facilities
Cluster of Excellence: Image-Guided and Functionally Instructed Tumor Therapies (iFIT)
Centers or interfaculty scientific institutions
Centers or interfaculty scientific institutions
Local organizational units
Pharmaceutical Institute
Department of Pharmacy and Biochemistry
Faculty of Science
Faculty of Science
Funders
Ulm, Baden-Württemberg, Germany